KELLI MILLS: Open Payments
NPI 1235622390 · LONDON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,813 in 92 payments from 16 companies in 2025. Trend: 2023 $1,153 · 2024 $1,440 · 2025 $1,813
Food & beverage: $1,813
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 23 | $410 |
| Janssen Pharmaceuticals, Inc | 6 | $263 |
| E.R. Squibb & Sons, L.L.C. | 8 | $247 |
| Alkermes, Inc. | 16 | $181 |
| ABBVIE INC. | 11 | $152 |
| Teva Pharmaceuticals USA, Inc. | 5 | $93 |
| Biogen, Inc. | 4 | $87 |
| Lundbeck LLC | 5 | $78 |
| Indivior Inc. | 2 | $73 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
Products named: SPRAVATO, HETLIOZ, COBENFY, FANAPT, VRAYLAR, REXULTI, ARISTADA, ZURZUVAE.
Industry payments across KY — which companies pay providers there.
